BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30746633)

  • 1. Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers.
    Savva C; De Souza K; Ali R; Rakha EA; Green AR; Madhusudan S
    Breast Cancer Res Treat; 2019 May; 175(1):105-115. PubMed ID: 30746633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.
    Abdel-Fatah TM; Middleton FK; Arora A; Agarwal D; Chen T; Moseley PM; Perry C; Doherty R; Chan S; Green AR; Rakha E; Ball G; Ellis IO; Curtin NJ; Madhusudan S
    Mol Oncol; 2015 Mar; 9(3):569-85. PubMed ID: 25468710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
    Abdel-Fatah TM; Arora A; Alsubhi N; Agarwal D; Moseley PM; Perry C; Doherty R; Chan SY; Green AR; Rakha E; Ball G; Ellis IO; Madhusudan S
    Neoplasia; 2014 Nov; 16(11):982-91. PubMed ID: 25425972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer.
    Feng X; Li H; Dean M; Wilson HE; Kornaga E; Enwere EK; Tang P; Paterson A; Lees-Miller SP; Magliocco AM; Bebb G
    Breast Cancer Res; 2015 May; 17(1):65. PubMed ID: 25935535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours.
    Green AR; Aleskandarany MA; Agarwal D; Elsheikh S; Nolan CC; Diez-Rodriguez M; Macmillan RD; Ball GR; Caldas C; Madhusudan S; Ellis IO; Rakha EA
    Br J Cancer; 2016 Apr; 114(8):917-28. PubMed ID: 26954716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.
    Al-Subhi N; Ali R; Abdel-Fatah T; Moseley PM; Chan SYT; Green AR; Ellis IO; Rakha EA; Madhusudan S
    Breast Cancer Res Treat; 2018 Jun; 169(2):277-286. PubMed ID: 29396668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
    Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
    Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas.
    Bueno RC; Canevari RA; Villacis RA; Domingues MA; Caldeira JR; Rocha RM; Drigo SA; Rogatto SR
    Ann Oncol; 2014 Jan; 25(1):69-75. PubMed ID: 24285016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2016 Jul; 158(2):233-41. PubMed ID: 27329169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?
    Abdel-Fatah TM; Perry C; Arora A; Thompson N; Doherty R; Moseley PM; Green AR; Chan SY; Ellis IO; Madhusudan S
    Antioxid Redox Signal; 2014 Dec; 21(16):2262-8. PubMed ID: 25111287
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Karamat U; Ejaz S; Hameed Y
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):263-275. PubMed ID: 33877897
    [No Abstract]   [Full Text] [Related]  

  • 13. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.
    Wang M; Liu G; Shan GP; Wang BB
    Cancer Biother Radiopharm; 2017 Aug; 32(6):193-203. PubMed ID: 28820634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.
    Abdel-Fatah TM; Albarakati N; Bowell L; Agarwal D; Moseley P; Hawkes C; Ball G; Chan S; Ellis IO; Madhusudan S
    Breast Cancer Res Treat; 2013 Dec; 142(3):515-27. PubMed ID: 24253812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
    Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers.
    Abdel-Fatah TM; Arora A; Moseley P; Coveney C; Perry C; Johnson K; Kent C; Ball G; Chan S; Madhusudan S
    BBA Clin; 2014 Dec; 2():10-7. PubMed ID: 26674120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer.
    Gulliver C; Hoffmann R; Baillie GS
    Int J Biochem Cell Biol; 2022 Jun; 147():106230. PubMed ID: 35609768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression.
    Di Benedetto A; Ercolani C; Mottolese M; Sperati F; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Di Lauro L; Barba M; Vitale I; Ciliberto G; Speirs V; De Maria R; Maugeri-Saccà M
    Sci Rep; 2017 Aug; 7(1):8078. PubMed ID: 28808232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Human ATR and ATM Inhibitors Modulate Single Strand DNA Formation in
    da Silva RB; Bertoldo WDR; Naves LL; de Vito FB; Damasceno JD; Tosi LRO; Machado CR; Pedrosa AL
    Front Cell Infect Microbiol; 2021; 11():802613. PubMed ID: 35059327
    [No Abstract]   [Full Text] [Related]  

  • 20. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
    Hahm ER; Lee J; Abella T; Singh SV
    Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.